Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Myelodysplastic Syndromes 10Hodgkin Disease 7Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia 5Myeloproliferative Disorders 4Leukemia, Prolymphocytic 4Leukemia, Myelomonocytic, Chronic 4Waldenstrom Macroglobulinemia 3Primary Myelofibrosis 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Burkitt Lymphoma 3Anemia, Refractory, with Excess of Blasts 3Lymphoma, Large-Cell, Anaplastic 2Lymphoma 2Leukemia, Biphenotypic, Acute 2Graft vs Host Disease 2Congenital Abnormalities 2Blast Crisis 2Thrombocythemia, Essential 1Sezary Syndrome 1Recurrence 1

Interventions

Cytarabine 16Methotrexate 13Specimen Handling 12venetoclax 11Cyclophosphamide 11fludarabine 8Whole-Body Irradiation 8Biopsy 8merphos 7fludarabine phosphate 7calaspargase pegol 7Vincristine 7Hydrocortisone 7blinatumomab 6Granulocyte Colony-Stimulating Factor 6Dexamethasone 6revumenib 5Mycophenolic Acid 5Leucovorin 5Filgrastim 5Daunorubicin 5Calcium Dobesilate 5Asparaginase 5prednylidene 4dexamethasone acetate 4dexamethasone 21-phosphate 4deltacortene 4Thioguanine 4Tacrolimus 4Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Biphenotypic, Acute × Cyclosporine × 90 days × Clear all
NCT04195633 2026-05-29

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Fred Hutchinson Cancer Center

Phase 2 Recruiting
60 enrolled
LymphoidMyeloidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04375631 2026-03-05

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Fred Hutchinson Cancer Center

Phase 1 Recruiting
120 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡